dbo:abstract |
Alcaftadine is used to prevent eye irritation brought on by allergic conjunctivitis. It is a H1 histamine receptor antagonist. It was approved by the U.S. Food and Drug Administration (FDA) in July 2010, under the trade name Lastacaft. (en) Алкафтадин — лекарственный препарат для лечения аллергического конъюнктивита. Одобрен для применения: США (2010). (ru) |
dbo:alternativeName |
Lastacaft (en) |
dbo:casNumber |
147084-10-4 |
dbo:chEBI |
71023 |
dbo:chEMBL |
1201747 |
dbo:drugbank |
DB06766 |
dbo:fdaUniiCode |
7Z8O94ECSX |
dbo:kegg |
D06552 |
dbo:medlinePlus |
a611022 |
dbo:pubchem |
19371515 |
dbo:thumbnail |
wiki-commons:Special:FilePath/Alcaftadine.svg?width=300 |
dbo:wikiPageExternalLink |
https://druginfo.nlm.nih.gov/drugportal/name/alcaftadine |
dbo:wikiPageID |
30791964 (xsd:integer) |
dbo:wikiPageLength |
8505 (xsd:nonNegativeInteger) |
dbo:wikiPageRevisionID |
1082640043 (xsd:integer) |
dbo:wikiPageWikiLink |
dbr:Conjunctivitis dbr:Allergic dbr:Receptor_antagonist dbc:Ophthalmology_drugs dbr:Irritation dbc:H1_receptor_antagonists dbr:Food_and_Drug_Administration dbr:Histamine dbc:AbbVie_brands dbc:Mast_cell_stabilizers dbr:Ketotifen |
dbp:atcPrefix |
S01 (en) |
dbp:atcSuffix |
GX11 (en) |
dbp:c |
19 (xsd:integer) |
dbp:casNumber |
147084 (xsd:integer) |
dbp:chebi |
71023 (xsd:integer) |
dbp:chembl |
1201747 (xsd:integer) |
dbp:chemspiderid |
14201635 (xsd:integer) |
dbp:dailymedid |
Alcaftadine (en) |
dbp:drugbank |
DB06766 (en) |
dbp:eliminationHalfLife |
7200.0 |
dbp:h |
21 (xsd:integer) |
dbp:iupacName |
2 (xsd:integer) |
dbp:iupharLigand |
7587 (xsd:integer) |
dbp:kegg |
D06552 (en) |
dbp:legalUs |
Rx-only (en) |
dbp:licenceUs |
Lastacaft (en) |
dbp:medlineplus |
a611022 (en) |
dbp:n |
3 (xsd:integer) |
dbp:o |
1 (xsd:integer) |
dbp:pregnancyUs |
B (en) |
dbp:pubchem |
19371515 (xsd:integer) |
dbp:routesOfAdministration |
Topical eye drops (en) |
dbp:smiles |
CN1CCCCC1 (en) |
dbp:stdinchi |
1 (xsd:integer) |
dbp:stdinchikey |
MWTBKTRZPHJQLH-UHFFFAOYSA-N (en) |
dbp:tradename |
Lastacaft (en) |
dbp:unii |
7 (xsd:integer) |
dbp:verifiedfields |
changed (en) |
dbp:verifiedrevid |
477316420 (xsd:integer) |
dbp:watchedfields |
changed (en) |
dbp:wikiPageUsesTemplate |
dbt:Cite_web dbt:Drugbox dbt:Portal_bar dbt:Reflist dbt:Short_description dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Ebicite dbt:Fdacite dbt:Keggcite dbt:Stdinchicite dbt:Drugs.com dbt:Histamine_receptor_modulators dbt:Antihistamines |
dcterms:subject |
dbc:Ophthalmology_drugs dbc:H1_receptor_antagonists dbc:AbbVie_brands dbc:Mast_cell_stabilizers |
rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:Adversary109773245 yago:CausalAgent100007347 yago:LivingThing100004258 yago:Object100002684 yago:Organism100004475 yago:Person100007846 yago:PhysicalEntity100001930 yago:WikicatH1ReceptorAntagonists yago:YagoLegalActor yago:YagoLegalActorGeo dbo:Drug yago:Whole100003553 |
rdfs:comment |
Alcaftadine is used to prevent eye irritation brought on by allergic conjunctivitis. It is a H1 histamine receptor antagonist. It was approved by the U.S. Food and Drug Administration (FDA) in July 2010, under the trade name Lastacaft. (en) Алкафтадин — лекарственный препарат для лечения аллергического конъюнктивита. Одобрен для применения: США (2010). (ru) |
rdfs:label |
Alcaftadine (en) Алкафтадин (ru) |
owl:sameAs |
freebase:Alcaftadine yago-res:Alcaftadine wikidata:Alcaftadine http://or.dbpedia.org/resource/ଆଲକାଫ୍ଟାଡାଇନ dbpedia-ru:Alcaftadine dbpedia-sh:Alcaftadine dbpedia-sr:Alcaftadine https://global.dbpedia.org/id/4MMws |
prov:wasDerivedFrom |
wikipedia-en:Alcaftadine?oldid=1082640043&ns=0 |
foaf:depiction |
wiki-commons:Special:FilePath/Alcaftadine.svg |
foaf:isPrimaryTopicOf |
wikipedia-en:Alcaftadine |
is dbo:wikiPageRedirects of |
dbr:ATC_code_S01GX11 dbr:ATCvet_code_QS01GX11 dbr:Lastacaft |
is dbo:wikiPageWikiLink of |
dbr:ATC_code_S01GX11 dbr:ATCvet_code_QS01GX11 dbr:ATC_code_S01 dbr:C19H21N3O dbr:List_of_drugs:_Al dbr:Lastacaft |
is foaf:primaryTopic of |
wikipedia-en:Alcaftadine |